Our initiative is proudly supported by world-leading cancer research institutions, funding organizations and patient associations, whose excellence and prestige underpin our mission.
These institutional endorsements ensure the scientific rigor, transparency, and unwavering commitment required to drive a transformative change in the future of RAS-targeted therapies.